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The intracellular TRPML channels have multiple biological roles, but the physiological stimuli that open them
remained unknown. In a previous issue of Chemistry & Biology, Grimm et al. report a high-throughput chem-
ical screen that identified a plethora of selective activators of TRPML3 that should open the way to fully char-
acterize these channels and their physiological roles.TRP is a remarkable family of cation chan-
nels that mediate numerous cellular func-
tions (Nilius et al., 2007). Most TRP chan-
nels are located in the plasma membrane
and mediate Ca2+ influx in response to,
among other things, receptor stimulation,
temperature changes, membrane stretch,
and noxious compounds that can access
the channels at the plasma membrane
(Nilius et al., 2007). The TRPML subfamily
of the TRP channels is unique in that these
channels are mostly expressed in intra-
cellular organelles, and the physiological
stimuli that open them are not known at
present.
The TRPML subfamily consists of three
members: the foundingmember TRPML1,
TRPML2 and TRPML3. TRPML1 was
identified as the protein mutated in the
lysosomal storage disease mucolipidosis
type IV (Bargal et al., 2000). TRPML2 was
found by database searches and TRPML3
was identified as the protein mutated in
mice with the varitint-waddler phenotype
(Di Palma et al., 2002). The varitint-
waddler phenotype is characterized by
auditory, vestibular, and melanocyte
phenotypes, which are caused by the
gain-of-function mutation A419P in the
predicted fifth transmembrane domain of
TRPML3 (Grimm et al., 2007; Kim et al.,
2007). TRPML1 is expressed in late endo-
somes and lysosomes (Treusch et al.,
2004), TRPML2 is found mainly in lyso-
somes (Venkatachalam et al., 2006), and
TRPML3 shuttles between multiple intra-
cellular compartments and the plasma
membrane (Kim et al., 2009). The wild-
type channel behavior in mammalian cells
is knownonly for TRPML3 that canbeacti-
vatedbypreincubation in lowNa+medium
(Kim et al., 2008), while, when expressed
in insect cells, TRPML2 displays some
spontaneous channel activity (Lev et al.,
2010). When the proline mutation in thepredicted fifth transmembrane domain
was inserted into TRPML2(A396P) and
TRPML1(V432P), the resulting channels
showed spontaneous activity (Grimm
et al., 2007). However, this mutation is
likely to affect channel behavior, since
TRPML3(A419P) has altered ionic selec-
tivity and Ca2+ permeability (Kim et al.,
2008), along with altered trafficking and
posttranslational modification (Kim et al.,
2007; van Aken et al., 2008).
The intracellular localization of the
TRPML channels, the lack of knowledge
of their physiological stimuli, and the
inactivity of the available clones of wild-
type TRPML1 and TRPML2 pose sig-
nificant difficulties in characterizing the
properties on these channels and in delin-
eating the physiological function of the
native channels. Grimm et al. (2010) over-
come these difficulties by conducting
a high-throughput screen for small mole-
cule activators of TRPML3. The screen
yielded 53 specific TRPML3 activators
with EC50 of <5 mM that can be classified
into 9 chemical scaffolds and 19 single-
tons. The most active compound was
the cell impermeant singleton dubbed
SN-2. Considering that most TRPML3 is
found in intracellular organelles, SN-2
may not be the ideal compound to study
the cellular role of TRPML3. Other com-
pounds, like the cell permeant SF-11,
may be more suitable for such studies.
Interestingly, two of the TRPML3 acti-
vators also activated TRPML1 (SF-21)
and TRPML2 (SF-22). These offer the
opportunity for the first time to charac-
terize the channel properties of the wild-
type TRPML1 and TRPML2 expressed in
mammalian cells and perhaps to study
the effect of their opening on cell function.
Of particular interest will be the effect of
channel activity on cellular trafficking, as
both TRPML1 (Treusch et al., 2004) andChemistry & Biology 17, March 26, 2010TRPML3 (Kim et al., 2009) were shown
to affect membrane trafficking and au-
tophagy. In addition, SF-21 and SF-22
can be lead compounds to develop
specific chemical activators and inhibitors
of TRPML1 and TRPML2, respectively.
Grimm et al. (2010) used the TRPML3
activators tomake the important observa-
tion that they did not evoke TRPML3
activity in cochlear hair cells, and only
SN-2 at high concentration activated
TRPML3 in melanocytes. The potential
explanations offered for this observation
are that TRPML3 in the plasmamembrane
of native cells is regulated to prevent its
opening by the TRPML3 activators;
TRPML3 may exist in complex with other
TRPML channels, and TRPML3 in the
complex is not responsive to the activa-
tors; or that the level of TRPML3 at the
plasma membrane of native cells is very
low. The latter appears to be the most
likely explanation, since TRPML3 can
function as a channel when expressed in
TRPML1/ cells (Kim et al., 2009) and
knockdown of TRPML1 had no effect of
the SN-2-mediated activation of TRPML3
in melanocytes (Grimm et al., 2010). In
addition, it is of note that hair cells ob-
tained from the varitint-waddler mouse
show robust TRPML3 current (van Aken
et al., 2008), indicating than when present
at the plasma membrane of hair cells,
TRPML3 is active as a channel.
A key future question is how the
different activators open TRPML3.
Answering this question will provide
important information on this and other
TRPML channels and possibly provide
insight into the function of other TRP
channels. A clue for how some of the
compounds are gating TRPML3 is pro-
vided by the observed synergism be-
tween low extracytosolic Na+ (Na+e-cyto)
and the compounds to activate TRPML3.ª2010 Elsevier Ltd All rights reserved 209
Figure 1. Predicted Topology of TRPML3 and Its Pore Structure
TRPML3 is predicted to have six transmembrane domains with cytoplasmic C and N termini and a large
extracytosolic loop between transmembrane domains 1 and 2 that resides in the lumen of intracellular
organelles or extracellularly when TRPML3 is in the plasma membrane. Shown are the position of
His252, -273, and -283 that regulate TRPML3 activity by H+ and Na+ and the predicted structure of the
TRPML3 pore. The position of the proline mutated in the varitint-waddler mouse (blue) and the pore aspar-
tates (magenta, green) are also shown. The poremodel was created by SWISS-MODEL server’s alignment
interface, using the KcsA potassium channel as template. A TRPML3 tetramer was created by aligning the
TRPML3 model with the KcsA tetramer using PyMol, and the figure was rendered with the same program.
We are indebted to Dr. Michael Dorwart, UT Southwestern Medical Center, for help with modeling the
TRPML3 pore.
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in thematurating organ of Corti, where it is
exposed to high K+, low Na+ endolymph
(Yamasaki et al., 2000). Exposing
TRPML3 to low Na+e-cyto is necessary to
open the channel, and the activated
channel spontaneously inactivates in the
presence of Na+e-cyto (Kim et al., 2008).
Grimm et al. tested the relationship
between low Na+e-cyto and the activators
SN-2 and SF-24 and found remarkable
synergism between them in activation
of TRPML3. Regulation of TRPML3 by
Na+e-cyto and H
+
e-cyto is mediated by
a string of three histidines in the large
extracytosolic loop of TRPML3 (Figure 1).
Mutations of His283 eliminates inhibition
by H+e-cyto and Na
+
e-cyto, whereas His252210 Chemistry & Biology 17, March 26, 2010and His273 facilitate the inhibition by
increasing access of H+ and Na+ to
His283 (Kim et al., 2008). It is thus
possible that SN-2 and the compounds
with the SF-24 scaffold act on the extrac-
ytosolic loop, perhaps the domain en-
compassing His 252, 273, and 283, to
open TRPML3.
It is expected that the various TRPML3
activators indentified by Grimm et al.
open the channel by multiple mecha-
nisms, since they belong to different
chemical scaffolds and some, like SF-11,
activate the channel by acting from the
cytoplasmic side. It will be of particular
interest to reveal the mechanism by
which the compounds belonging to dif-
ferent scaffolds and the singletons openª2010 Elsevier Ltd All rights reservedTRPML3 and on what TRPML3 domain
they act. An obvious target is the TRPML3
pore. Figure 1 shows the predicted archi-
tecture of the TRPML3 pore and the posi-
tion of the A419P mutation in the fifth
transmembrane domain (blue) and of
two aspartates in the pore helix (green
and magenta), which when mutated to
alanines results in channel-dead TRPML3
(Kim et al., 2009). Accessing either of
these sites from the cytosolic or extracy-
tosolic sides by any of the compounds
can result in channel opening. Finding
the mechanism of action of the remark-
ably diverse chemical activators of
TRPML3 has the promise of yielding
ample information on the properties and
the cellular function of TRPML3 and other
members of the subfamily.
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